We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 5,450 results
  1. Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia

    Loss of TGF-β-mediated growth suppression is a major contributor to the development of cancers, best exemplified by loss-of-function mutations in...

    Li**g Wang, Shuchen Gu, ... **n-Hua Feng in Signal Transduction and Targeted Therapy
    Article Open access 24 March 2023
  2. MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis

    Breast cancer (BC) bone metastasis is primarily osteolytic and has limited therapeutic options. Metastasized BC cells prime the secondary environment...

    R. L. Akshaya, I. Saranya, N. Selvamurugan in Breast Cancer
    Article 14 August 2023
  3. Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma

    Lung squamous cell carcinoma (LUSC) is the second most common lung cancer worldwide, leading to millions of deaths annually. Although immunotherapy...

    He Tian, Ran Wei, ... Jie He in BMC Pulmonary Medicine
    Article Open access 25 January 2024
  4. Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias

    Hasan Issa, Raj Bhayadia, ... Jan-Henning Klusmann in Leukemia
    Article Open access 13 June 2023
  5. Circulating myeloid-derived suppressors cells correlate with clinicopathological characteristics and outcomes undergoing neoadjuvant chemoimmunotherapy in non-small cell lung cancer

    Purpose

    Myeloid-derived suppressors cells (MDSCs) are heterogeneous immunosuppressive cells, closely related to the development, efficacy and...

    T. Wen, C. Su, ... Z. Liu in Clinical and Translational Oncology
    Article 06 January 2022
  6. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia

    Background

    Recent studies have reported that cuproptosis, a novel cell death pathway, strongly correlates with mitochondrial metabolism. In addition,...

    Dongmei Luo, Songyang Liu, ... Na Xu in Clinical and Translational Oncology
    Article 24 February 2023
  7. KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition

    Acute myeloid leukemia (AML) is a heterogeneous, aggressive malignancy with dismal prognosis and with limited availability of targeted therapies....

    Liberalis Debraj Boila, Subhadeep Ghosh, ... Amitava Sengupta in Leukemia
    Article 31 January 2023
  8. Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial

    Despite the effectiveness of tyrosine kinase inhibitors (TKIs) against chronic myeloid leukemia (CML), they are not usually curative as some patients...

    Ryan Yen, Sarah Grasedieck, ... **aoyan Jiang in Leukemia
    Article 23 August 2022
  9. Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape

    The quest for treatment-free remission (TFR) and deep molecular response (DMR) in chronic myeloid leukemia (CML) has been profoundly impacted by...

    Ya-Ching Hsieh, Kristina Kirschner, Mhairi Copland in Leukemia
    Article Open access 08 April 2021
  10. Use of Magnetotactic Bacteria as an MRI Contrast Agent for In Vivo Tracking of Adoptively Transferred Immune Cells

    Purpose

    In vivo immune cell tracking using MRI can be a valuable tool for studying the mechanisms underlying successful cancer therapies. Current...

    Andrea Nuschke, Caitrin Sobey-Skelton, ... Kimberly Brewer in Molecular Imaging and Biology
    Article 15 September 2023
  11. IL-17-producing γδT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1+CD11b+ myeloid-derived suppressor cells

    Acute graft-versus-host disease (aGVHD) is the most severe complication and the major cause of morbidity and mortality in patients who have received...

    Lin Xu, **g**g Feng, ... He Huang in Bone Marrow Transplantation
    Article 13 May 2021
  12. Myeloid liver kinase B1 contributes to lung inflammation induced by lipoteichoic acid but not by viable Streptococcus pneumoniae

    Background

    Liver kinase B1 (Lkb1, gene name Stk11 ) functions as a tumor suppressor in cancer. Myeloid cell Lkb1 potentiates lung inflammation induced...

    Liza Pereverzeva, Natasja A. Otto, ... Tom van der Poll in Respiratory Research
    Article Open access 12 September 2022
  13. Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis

    Morphogenesis and organogenesis in the low organisms have been found to be modulated by a number of proteins, and one of such factor, deformed...

    Longji Wu, **g Huang, ... **angning Zhang in Discover Oncology
    Article Open access 15 December 2022
  14. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors

    Myeloid-derived suppressor cells (MDSCs) are widely implicated in negative regulation of immune responses in cancer. Inhibition of class I histone...

    Ayumi Hashimoto, Takeshi Fukumoto, ... Dmitry Gabrilovich in Cancer Immunology, Immunotherapy
    Article 20 May 2020
  15. Myeloid cell heterogeneity in lung cancer: implication for immunotherapy

    Lung is a specialized tissue where metastases from primary lung tumors takeoff and those originating from extra-pulmonary sites land. One commonality...

    Sabina Sangaletti, Roberto Ferrara, ... Mario Paolo Colombo in Cancer Immunology, Immunotherapy
    Article 02 April 2021
  16. SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model

    Dysregulated fatty acid metabolism interacts with oncogenic signals, thereby worsening tumor aggressiveness. The stearoyl-CoA desaturating enzymes,...

    Maria Bellenghi, Giovanna Talarico, ... Sabina Sangaletti in Oncogene
    Article 18 July 2022
  17. Autophagy in acute myeloid leukemia: a paradoxical role in chemoresistance

    Autophagy is a lysosomal degradation pathway that is constitutively active in almost every cell of our body at basal level. This self-eating process...

    Aafreen Khan, Vivek Kumar Singh, ... Ritu Gupta in Clinical and Translational Oncology
    Article 26 February 2022
  18. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia

    Purpose

    Prognostic prediction is a challenging task in cytogenetically normal acute myeloid leukemia (CN-AML) patients. In this study, we aimed at...

    Cong Deng, Tiansheng Zeng, ... Lin Fu in Journal of Cancer Research and Clinical Oncology
    Article 01 June 2023
  19. Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels

    Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder distinguished by a specific genetic anomaly known as a reciprocal translocation...

    Manvi Bansal, Sana Ansari, Malkhey Verma in Medical Oncology
    Article 12 January 2024
  20. Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells

    Over the past decade, US Food and Drug Administration (FDA)-approved immune checkpoint inhibitors that target programmed death-1 (PD-1) have...

    Narendiran Rajasekaran, **aoguang Wang, ... Sanjay D Khare in Cancer Immunology, Immunotherapy
    Article Open access 24 February 2024
Did you find what you were looking for? Share feedback.